Free Trial
OTCMKTS:NBIO

Nascent Biotech (NBIO) Stock Price, News & Analysis

Nascent Biotech logo
$0.08
0.00 (0.00%)
(As of 10/31/2024 ET)

About Nascent Biotech Stock (OTCMKTS:NBIO)

Key Stats

Today's Range
$0.08
$0.08
50-Day Range
$0.04
$0.09
52-Week Range
$0.03
$0.28
Volume
N/A
Average Volume
103,119 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

Receive NBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nascent Biotech and its competitors with MarketBeat's FREE daily newsletter.

NBIO Stock News Headlines

This man believes TSLA will reach $500 a share…
Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.
Nascent Biotech Inc NBIO
See More Headlines

NBIO Stock Analysis - Frequently Asked Questions

Nascent Biotech's stock was trading at $0.1729 at the start of the year. Since then, NBIO shares have decreased by 56.6% and is now trading at $0.0750.
View the best growth stocks for 2024 here
.

Shares of NBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nascent Biotech investors own include Fulcrum Therapeutics (FULC), Evelo Biosciences (EVLO), VIVUS (VVUS), Applied Therapeutics (APLT), Ocugen (OCGN), Processa Pharmaceuticals (PCSA) and Rigel Pharmaceuticals (RIGL).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:NBIO
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:NBIO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners